Recombinant TIGIT (Domvanalimab Biosimilar) antibody

Catalog No. ABIN7597633

The Humanized Chimeric anti-TIGIT (Domvanalimab Biosimilar) antibody is suitable to detect TIGIT (Domvanalimab Biosimilar) in samples from Human.

Quick Overview for Recombinant TIGIT (Domvanalimab Biosimilar) antibody (ABIN7597633)

Target: TIGIT (Domvanalimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This TIGIT (Domvanalimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-TIGIT (Domvanalimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Domvanalimab Biosimilar Antibody

Specificity: VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for TIGIT (Domvanalimab Biosimilar)

Target: TIGIT (Domvanalimab Biosimilar)

Alternative Name: Domvanalimab Biosimilar

Target Type: Biosimilar

Background: VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains

UniProt: Q495A1

CAS-No: 2368219-35-4